Comparison
46 Xx Disorder Of Sex Development C2936403 vs 3 Methylglutaric Aciduria C3151952
Clinical comparison between 46 XX Disorder OF Sex Development and 3 Methylglutaric Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development C2936403
A variation in typical female sex development involving chromosomal, gonadal, or anatomical differences. Treatment and support are personalized based on individual medical needs.
3 Methylglutaric Aciduria C3151952
An organic acidemia affecting how the body processes certain amino acids. It can cause neurological problems and metabolic crises. Management involves dietary changes and supportive treatment.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development C2936403
0-0
3 Methylglutaric Aciduria C3151952
0-10
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development C2936403
severe
3 Methylglutaric Aciduria C3151952
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development C2936403
Chronic
3 Methylglutaric Aciduria C3151952
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development C2936403
No
3 Methylglutaric Aciduria C3151952
No
Different transmission
Body System
46 Xx Disorder Of Sex Development C2936403
reproductive
3 Methylglutaric Aciduria C3151952
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development C2936403
genetic
3 Methylglutaric Aciduria C3151952
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-C2936403 and 3-methylglutaric-aciduria-C3151952 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development C2936403 | 3 Methylglutaric Aciduria C3151952 | Discriminating power |
|---|---|---|---|
| Genital or gonadal difference | May involve atypical genital, gonadal, or internal reproductive anatomy from birth. | Not defined by sex-development anatomy; such findings are not an established feature. | High |
| Metabolic crisis | Metabolic decompensation is not an established feature of this condition. | May involve episodic illness with neurologic change; exact triggers and severity vary. | High |
| Developmental or neurologic concern | Not established as a core feature; assess individually rather than assume. | Neurologic problems are described, but specific deficits are not established here. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development C2936403 when
Atypical genital or gonadal findings with 46,XX context
The presentation centers on sex development rather than organic-acid metabolism.
High
Need for endocrine, surgical, or fertility counseling
Care is personalized around anatomy, hormones, and reproductive goals.
Moderate
No biochemical evidence of organic acidemia
Absence of the metabolic pattern makes the aciduria less fitting, pending full evaluation.
Moderate
Choose 3 Methylglutaric Aciduria C3151952 when
Suspected organic acidemia or metabolic decompensation
The condition concerns amino-acid processing and possible metabolic crises.
High
Neurologic symptoms with abnormal organic-acid testing
Combined clinical and biochemical findings support metabolic evaluation.
Moderate
Childhood onset without a sex-development phenotype
Supplied onset extends through childhood and the primary system is metabolic.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development C2936403 | 3 Methylglutaric Aciduria C3151952 | Interpretation |
|---|---|---|---|
| Karyotype and sex-development evaluation | 46,XX context with clinical gonadal or anatomical assessment. | No established sex-chromosome abnormality is required. | Supports the left concept only with compatible anatomy; it does not diagnose the aciduria. |
| Urine organic acids | No established diagnostic metabolite pattern. | May show elevated 3-methylglutaric acid and related metabolites; cutoffs are not supplied. | An abnormal result suggests a metabolic disorder but requires specialist confirmation. |
| Metabolic crisis evaluation | Not routinely indicated by the diagnosis alone. | Clinically directed glucose, acid-base, and ammonia assessment may be used. | Results guide acute care; they do not by themselves prove either diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development C2936403
- Outcome
- Chronic course with highly individualized outcomes; definitive prognosis is not established.
- Factors
- Anatomy, endocrine function, associated conditions, and access to supportive care.
3 Methylglutaric Aciduria C3151952
- Outcome
- Chronic metabolic disorder with possible neurologic effects or crises; exact outcome is not established.
- Factors
- Crisis prevention, neurologic status, dietary management, and associated metabolic defects.
Time frame: Left is present from birth; right may present from birth through age 10 in the supplied data.
Supplied severity differs, but these labels should not be treated as individual prognoses.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive or endocrine complications | Hormone, fertility, or anatomical concerns may occur and need individualized care. Not an established defining complication. Exact frequency and outcomes are not established. |
| Acute metabolic decompensation | Not an established complication. Crises may occur; warning features and severity vary. No mortality or laboratory threshold is established by these data. |
| Neurologic injury | Not established as characteristic. Neurologic problems are described and may relate to metabolic illness. Causation and permanence cannot be determined from the supplied description. |
Patient education highlights
- HighDifferent conditions
One concerns sex development; the other is a metabolic disorder. A label or abnormal test is not automatically a complete diagnosis.
- HighUrgent symptoms
For suspected aciduria, seek urgent care for reduced responsiveness, persistent vomiting, seizures, or unusual breathing. Exact thresholds are clinician-defined.
- MediumPersonalized support
Sex-development care should respect privacy, consent, and individual medical goals; metabolic care may include diet and specialist follow-up.